Fig. 5From: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort studyHospital readmission following FF/UMEC/VI initiation. FF/UMEC/VI fluticasone furoate/umeclidinium/vilanterol, CI confidence interval, COPD chronic obstructive pulmonary disease. p-values in bold text indicate statistical significanceBack to article page